Pharmacologic Management
The historical approach to the management of RA was to maintain the patient on non-steroidal anti-inflammatory drugs (NSAIDs) for as long as possible, only to add more potent medications when the patient's disease had progressed.[1,4] The current approach to management is to initiate a disease-modifying, anti-rheumatic drug (DMARD) within 3 months of diagnosis